Evidence map›Paper›PMID 26801641›Full record

ArticleNucleic acids research2016

Enrichment of Cdk1-cyclins at DNA double-strand breaks stimulates Fun30 phosphorylation and DNA end resection.

Xuefeng Chen, Hengyao Niu, Yang Yu, Jingjing Wang, Shuangyi Zhu, Jianjie Zhou, Alma Papusha, Dandan Cui, Xuewen Pan, Youngho Kwon and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Nucleosome Remodeling by Fun30Frontiers in molecular biosciences · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Xuefeng ChenCollege of Life Sciences and Institute for Advanced Studies, Wuhan University, Wuhan, Hubei 40072, China xfchen@whu.edu.cn.
Hengyao NiuDepartment of Biochemistry and Biophysics, Yale University School of Medicine, New Haven, CT, USA.
Yang YuDepartment of Molecular ad Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Jingjing WangCollege of Life Sciences and Institute for Advanced Studies, Wuhan University, Wuhan, Hubei 40072, China.
Shuangyi ZhuCollege of Life Sciences and Institute for Advanced Studies, Wuhan University, Wuhan, Hubei 40072, China.
Jianjie ZhouCollege of Life Sciences and Institute for Advanced Studies, Wuhan University, Wuhan, Hubei 40072, China.
Alma PapushaDepartment of Molecular ad Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Dandan CuiDepartment of Molecular ad Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Xuewen PanDepartment of Molecular ad Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Youngho KwonDepartment of Biochemistry and Biophysics, Yale University School of Medicine, New Haven, CT, USA.
Patrick SungDepartment of Biochemistry and Biophysics, Yale University School of Medicine, New Haven, CT, USA patrick.sung@yale.edu.
Grzegorz IraDepartment of Molecular ad Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA gira@bcm.edu.
Baylor College of Medicine · USWuhan University · CNYale University · US

Funding

YEAST DNA REPAIR GENES AND PROTEINS OF THE RAD52 GROUPR01ES007061 · NIEHS · YALE UNIVERSITY · PI Patrick Sung · 1995 to 2026
$9.4M
Regulation of DNA recombination in Saccharomyces cerevisiaeR01GM080600 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI IRA, GRZEGORZ A · 2007 to 2024
$5.5M
Roles of the RecQ Helicases BLM and RECQ5 in Genome MaintenanceR01ES015632 · NIEHS · YALE UNIVERSITY · PI SUNG, PATRICK · 2007 to 2017
$3.9M
Mechanisms and Crosstalk of DNA Break Resection PathwaysR00ES021441 · NIEHS · TRUSTEES OF INDIANA UNIVERSITY · PI NIU, HENGYAO · 2015 to 2017
$747k
NIEHS NIH HHS ES007061NIEHS NIH HHS ES015632NIEHS NIH HHS ES021441NIEHS NIH HHS R00 ES021441NIEHS NIH HHS R01 ES007061NIEHS NIH HHS R01 ES015632NIGMS NIH HHS GM080600NIGMS NIH HHS R01 GM080600
6 · The paper itself

Abstract

DNA double-strand breaks (DSBs) are one of the most cytotoxic types of DNA lesion challenging genome integrity. The activity of cyclin-dependent kinase Cdk1 is essential for DSB repair by homologous recombination and for DNA damage signaling. Here we identify the Fun30 chromatin remodeler as a new target of Cdk1. Fun30 is phosphorylated by Cdk1 on Serine 28 to stimulate its functions in DNA damage response including resection of DSB ends. Importantly, Cdk1-dependent phosphorylation of Fun30-S28 increases upon DNA damage and requires the recruitment of Fun30 to DSBs, suggesting that phosphorylation increases in situ at the DNA damage. Consistently, we find that Cdk1 and multiple cyclins become highly enriched at DSBs and that the recruitment of Cdk1 and cyclins Clb2 and Clb5 ensures optimal Fun30 phosphorylation and checkpoint activation. We propose that the enrichment of Cdk1-cyclin complexes at DSBs serves as a mechanism for enhanced targeting and modulating of the activity of DNA damage response proteins.

Indexed as

DNA Breaks, Double-StrandedGene Expression Regulation, FungalAmino Acid SequenceCDC2 Protein KinaseChromatinChromatin Assembly and DisassemblyCyclin BDNA End-Joining RepairEscherichia coliMolecular Sequence DataRecombinant ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSequence AlignmentSerineTranscription FactorsCDC2 Protein KinaseChromatinCLB2 protein, S cerevisiaeCLB5 protein, S cerevisiaeCyclin BFUN30 protein, S cerevisiaeRecombinant ProteinsSaccharomyces cerevisiae ProteinsSerineTranscription Factors

Identifiers

PMID26801641
PMCPMC4824098
OpenAlexW2261484780

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.